In the News
Pivot Bio broke the code on using microbes to get crops to self-fertilize, allowing farmers to replace their synthetic fertilizers. It's now worth nearly $2 billion.
A startup born in the lab of University of California, Berkeley, is aiming to replace synthetic fertilizers that contribute to greenhouse gases and so-called 'dead zones' in the ocean.
A new microbial product from Pivot Bio could help them maximize nitrogen efficiency by creating a strong connection with the plant and delivering a reliable yet consistent supply of nitrogen.
New forms of farming equipment could make it easier for growers to apply nitrogen fertilizer as well as other inputs — in other words, make precision agriculture more precise.
Learn more about how Pivot Bio's microbes work, the impact on farmers, and how biology is poised to transform agriculture.
The world’s brightest tech founders are investing in synthetic biology, including Microsoft founder Bill Gates who helped fund Pivot Bio.
Pivot Bio secured $100 million in its Series C funding round, backed by Bill Gates’s Breakthrough Energy Ventures and global investment firm Temasek.
Pivot Bio aims to change that with new technology that reduces the environmental footprint of agriculture while increase farmers crop output and revenue.
After closing its $100 million Series C funding round, Pivot Bio will accelerate its plans to scale its first-to-market microbial nitrogen technology that increases crop yields and farmer revenue.
The Berkeley, CA-based startup has announced the closing of a $100 million Series C round co-led by return investors Breakthrough Energy Ventures.
A century after nitrogen fertilizer was introduced, a new group of scientists backed by government-owned international investment funds and some of the world’s wealthiest men and women is trying to save the world from
Selected as a top 50 AgTech company by SVG Ventures, Pivot Bio was chosen in the biotechnology sector because it exemplifies the best in agriculture innovation.
Pivot Bio was named to Fast Company’s most innovative biotechnology companies, which reflects the push in pharmaceuticals to expand past lucrative cures and focus on desperately needed solutions.
Central Iowa farmer Scott Henry changed course for 2020, swapping his traditional nitrogen program for Pivot Bio PROVEN™’s sustainable nitrogen-producing microbes.
East Bay EDA announced the Finalists for their 8th Annual East Bay Innovation Awards.
Recipients have been announced, celebrating companies in the region that demonstrate exceptional achievements in innovation, sustainability and market leadership.
Growing food around the world will only get harder as weather gets harsher and more unpredictable.
The bacteria will help the corn plants convert nitrogen from the atmosphere into a form the corn plants can use as fertilizer. The idea is to eventually replace synthetic nitrogen fertilizer with microbes.
Pivot Bio touted its microbe technology as a way to increase production by more than 7 bushels per acre in normal soil and 17 bushels an acre in sandy soil when tested against fields with traditional nitrogen fertilizer.
What if we could fertilize plants without releasing harmful nitrous oxide into the air? Bill Gates highlights several companies, including Pivot Bio, that are developing creative solutions.
Nitrogen-fixing bacteria may not sound like the most alluring topic, but it’s capturing the attention of the world’s most influential billionaires, who see it as a concrete way to help save the planet.
Scientists build novel microbe that lets us re-imagine how we grow food.
Pivot Bio makes the world’s first nitrogen-producing microbial that grafts onto corn to act as a sustainable fertilizer.
In a six-year trial, spanning 13 states, 45 different soil types, and 11,000 acres, farms using PROVEN produced on average 7.7 bushels of corn more per acre than those using traditional synthetic fertilizer.
The San Francisco-based startup has now completed over 11,000 field trials of its microbes with Midwest farmers, bringing the company one step closer to commercialization.
The 37th annual J.P. Morgan Healthcare Conference, along with the Biotech Showcase, Startup Health Festival and other conferences in San Francisco this week, feature big names, such as Amgen Inc., Gilead Sciences Inc.,
Here’s our annual list of promising enterprise startups who did so well in 2018, they are poised for future success in 2019 and beyond.
Technology is evolving at an exponential pace and undoubtedly a year from now the landscape will look different than it does today. Here’s what tech insiders see coming around the bend.
As the year winds down, we’re reflecting on the big innovation trends and developments that will carry over to next year.
It was a year of frightening reports on the future of our planet. But sustainability experts are still feeling optimistic about some of the strides we’ve made this year.
Earlier this week Pivot Bio and Monsanto Company, a member of the Bayer group, announced a collaboration they entered earlier this year to develop a new soybean inoculant. The collaboration focuses on developing
Fertilizing is essential to yielding a healthy harvest, but it’s expensive enough that he stresses about it, and, as he’s well aware, it’s not great for the planet.
“If we can start reducing the pollution tied to fertilizer, then we’re literally cleaning up the planet,” said Karsten Temme, the company’s chief executive, in an interview.
Scientists at agriculture startup Pivot Bio say the key to delivering an important nutrient to crops has been at the plants’ roots all along—and the company is now preparing to offer farmers an alternative to fertilizer.